March 22, 2010 – Diversified Search Odgers Berndtson has recruited Russ Kronengold, Ph.D., as chief scientific officer of Aperion Biologics. Dr. Kronengold was previously vice president of research and development at Kensey Nash. The search was conducted by Henry J. Scherck, managing director and practice leader of the firm’s life sciences unit. Diversified Search, headquartered in Philadelphia, offers global search capabilities with industry specialization in consumer & industrial; education, not-for-profit, arts & culture; financial & professional services; healthcare & human services; private equity/venture capital; retail; life sciences; media & entertainment; and technology.
Share This Article